PAK4, highly expressed in lung cancers, counteracts the anti-proliferative effect induced by TGFβ/FH/CSL cascade by phosphorylating FH on Ser46, an event that—contrarily to the phosphorylation on Thr90—impairs the interaction between FH and CSL, favoring tumor proliferation and metastasis. This evidence concerns the gene FH and lung carcinoma.